Lidia Blay

Dr. Lidia Blay

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2021 in Surgical Oncology
Verified
Journal Article
Closed access
AMAntonio Mariscal Martínez
Antonio Mariscal Martínez
IRIrene Vives Roselló
Irene Vives Roselló
AGAngela Salazar Gómez
Angela Salazar Gómez
ACAlessandro Catanese
Alessandro Catanese
MMMariola Pérez Molina
Mariola Pérez Molina
MTMiguel Angel Luna Tomás
Miguel Angel Luna Tomás

1 February 2019 in Cirugía Española
Verified
Journal Article
Closed access
LBLidia Blay
Lidia Blay
JLJavier Louro
Javier Louro
TBTeresa Barata
Teresa Barata
MBMarisa Baré
Marisa Baré
JFJoana Ferrer
Joana Ferrer
MSMaria Sala
Maria Sala

12 October 2024 in Cells
Verified
Journal Article
Open access
PDF file
DHDaniel Humaran
Daniel Humaran
JPJaviera Perez-Anker
Javiera Perez-Anker
PFPedro Luis Fernández
Pedro Luis Fernández
LBLidia Blay
Lidia Blay
IMIciar Pascual Miguel
Iciar Pascual Miguel
JJJoan Francesc Julián
Joan Francesc Julián
Ex vivo fusion confocal microscopy (EVFCM) enables the rapid examination of breast tissue and has the potential to reduce the surgical margins and the necessity for further surgeries. Traditional methods, such as frozen section analysis, are limited by the distortion of tissue and artefacts, leading to false negatives and the need for additional surgeries. This study on observational diagnostic accuracy evaluated the ability of EVFCM to detect breast cancer. A total of 36 breast tissue samples, comprising 20 non-neoplastic and 16 neoplastic cases, were analysed using EVFCM and compared to the results obtained from routine histopathology. A Mohs surgeon experienced in EVFCM (evaluator A) and two breast pathologists unfamiliar with EVFCM (evaluators B and C) performed blinded analyses. EVFCM showed high concordance with the histopathology and the detection of neoplasia, with significant kappa values (p < 0.001). Evaluator A achieved 100% sensitivity and specificity. Evaluators B and C achieved a sensitivity of >87%, a specificity of >94%, positive predictive values of >95%, and negative predictive values of 81% and 94%, respectively. EVFCM therefore offers a promising technique for the assessment of margins in breast-conserving surgery. Its widespread adoption could significantly reduce re-excisions, lower healthcare costs, and improve cosmetic and oncological outcomes.

1 March 2020 in Surgical Oncology
Verified
Journal Article
Closed access
LBLidia Blay
Lidia Blay
MPManel Cremades Pérez
Manel Cremades Pérez
Jordi Navinés-LópezJordi Navinés-López
Jordi Navinés-López
IMIciar Pascual Miguel
Iciar Pascual Miguel
CLCristian carrasco lopez
Cristian carrasco lopez
JJJoan Francesc Julián
Joan Francesc Julián

30 November 2025 in Cancers
Verified
Journal Article
Open access
PDF file
DHDaniel Humaran
Daniel Humaran
ACAna Castillo
Ana Castillo
LBLidia Blay
Lidia Blay
IMIciar Pascual Miguel
Iciar Pascual Miguel
KMKarol Matute-Molina
Karol Matute-Molina
JJJoan Francesc Julián
Joan Francesc Julián
Background/Objectives: Accurate intraoperative margin assessment is essential for ensuring complete tumour excision in breast-conserving surgery, minimising local recurrence, and avoiding reoperations. Ex vivo fusion confocal microscopy (EVFCM) provides real-time, high-resolution imaging of fresh, unfixed tissues that closely resembles conventional histological imaging. This study aimed to validate the diagnostic performance and clinical feasibility of EVFCM for real-time intraoperative margin assessment during breast cancer surgery. Methods: A prospective observational diagnostic validation study was conducted using 144 breast tissue specimens. The samples were stained with acridine orange and fast green and scanned using a VivaScope 2500M-G4 system. Two breast pathologists independently evaluated the EVFCM images, blinded to the conventional histology results, which served as the reference standard. The diagnostic accuracy, sensitivity, specificity, and interobserver agreement were calculated using Cohen’s κ. Results: Interobserver agreement was almost perfect for neoplasia detection (97.3%, κ = 0.942) and tumour type classification (93.8%, κ = 0.883). The EVFCM achieved 93.7% sensitivity and specificity, with 94.0% accuracy for tumour detection (κ = 0.929, p < 0.001); 95.8% accuracy for tumour type classification (κ = 0.925, p < 0.001); and 95.1% accuracy for invasive subtype identification (κ = 0.907, p < 0.001). For margin assessment, EVFCM achieved 80% sensitivity, 100% specificity, and 99.3% accuracy (κ = 0.857, p < 0.001), whereas margin distance evaluation (<2 mm vs. ≥2 mm) yielded 75% sensitivity, 100% specificity, and 98.6% accuracy (κ = 0.854, p < 0.001). Conclusions: EVFCM enables rapid, high-resolution imaging of fresh breast tissue, facilitating real-time intraoperative margin evaluation with excellent diagnostic concordance and workflow efficiency. Its integration into surgical practice could reduce re-excisions, enhance oncological safety, and improve patient outcomes in breast-conserving surgeries.

19 January 2024 in Cirugía Española
Verified
Journal Article
Closed access
LBLidia Blay
Lidia Blay
ILItziar Larrañaga
Itziar Larrañaga
EYElisa York
Elisa York
LRLorenzo Rabadán
Lorenzo Rabadán